Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database
Authors:
- Maria Werner-WasikMWMaria Werner-Wasik
- Rebecca PaulusRPRebecca Paulus
- Walter J. CurranWCWalter J. Curran
- Roger ByhardtRBRoger Byhardt
- 1 July 2011
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 12 (4) , 245-251
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non–small-cell lung cancer (a Vanderbilt cancer center affiliate network study)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 rtog patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Concurrent radiochemotherapy for patients with stage III non-small–cell lung cancer (NSCLC): long-term results of a phase II studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1998
- Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small-cell carcinoma of the lungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee.Journal of Clinical Oncology, 1998
- Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15Cancer, 1995
- Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993